Enhancement Medical expression. model # EXP-150. Injectable Gel 1.5cc Syringe with hyaluronic acid concentration of 20 mg/ml. Product Usage: Expression is labelled as an Intranasal Splint, intended to minimize bleeding and edema and to prevent adhesions between the septum and the nasal cavity. However, Expression is currently being used off-label as a subcutaneously injected dermal filler.
Publicado el 20 de agosto de 2014 · Inicio del retiro: 7 de agosto de 2013
Resumen
FDA registra el retiro Z-2135-2014 de dispositivos médicos de Clase I, publicado el 20 de agosto de 2014 e iniciado el 7 de agosto de 2013. Empresa responsable: Enhancement Medical, LLC; Estado: Finalizado; Cantidad reportada: 17,875; Lote: Lot numbers to follow: Z36-074, Q36-136, Q36-137, Q36-138, Q36-139, Q36-140, R36-168, R36-169, R36-170, R36-171, R36-172, S36-189, S36-190, S36-191, S36-192, S36-194, S36-202, S36-203. RECALL EXPANDED 7-8-2014 to include ALL LOTS. La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Manufacturer made a change in the production process that resulted in a change in final gel weight. RECALL EXPANDED 7/8/2014 Firm expanded their recall to include all lots of product.
Qué hacer
Voluntary: Firm initiated · Visit
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Enhancement Medical, LLC
- Distribuidor
- Worldwide Distribution - USA (nationwide including Puerto Rico) and Internationally to Canada.
- Lote
- Lot numbers to follow: Z36-074, Q36-136, Q36-137, Q36-138, Q36-139, Q36-140, R36-168, R36-169, R36-170, R36-171, R36-172, S36-189, S36-190, S36-191, S36-192, S36-194, S36-202, S36-203. RECALL EXPANDED 7-8-2014 to include ALL LOTS.
- Clasificación de riesgo
- Class I
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAGYC-1000 Green Laser Photocoagulator system The Nidek Green Laser Photocoagulator Model GYC -1000 is indicated20 de agosto de 2014
- FDACSI Cardiovascular Systems, Inc., Diamondback 360 Peripheral Orbital Atherectomy System, Model Number20 de agosto de 2014
- FDACool Tropics Rips Slush, Cherry LimeadeFlavored 100% Juice No artificial colors or flavors, Juice from20 de agosto de 2014
- FDAEsaote PA230E Transducer A portable and cart base ultrasound system for general and cardiovascular imaging20 de agosto de 2014
- FDACool Tropics Rips Slush, Blue Raspberry Flavored 100% Juice No artificial colors or flavors, Juice from20 de agosto de 2014
- FDANanosphere Verigene Each CDF test consists of a Verigene CDF Nucleic Acid Test Kit and a Verigene CDF20 de agosto de 2014
Preguntas sobre este retiro
¿Enhancement Medical expression. model # EXP-150. Injectable Gel 1.5cc Syringe with hyaluronic acid concentration of 20 mg/ml. Product Usage: Expression is labelled as an Intranasal Splint, intended to minimize bleeding and edema and to prevent adhesions between the septum and the nasal cavity. However, Expression is currently being used off-label as a subcutaneously injected dermal filler. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2135-2014 el 20 de agosto de 2014. Peligro reportado: Manufacturer made a change in the production process that resulted in a change in final gel weight. RECALL EXPANDED 7/8/2014 Firm expanded their recall to include all lots of product.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Visit